Compare · AHCO vs OPCH
AHCO vs OPCH
Side-by-side comparison of AdaptHealth Corp. (AHCO) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AHCO and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.54B, about 4.7x AHCO ($747.2M).
- AHCO has hit the wire 7 times in the past 4 weeks while OPCH has been quiet.
- OPCH has more recent analyst coverage (17 ratings vs 12 for AHCO).
- Company
- AdaptHealth Corp.
- Option Care Health Inc.
- Price
- -
- -
- Market cap
- $747.2M
- $3.54B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 7
- 0
- Recent ratings
- 12
- 17
AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest AHCO
- ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health
- Director Samet Kenneth A bought $149,930 worth of shares (23,500 units at $6.38), increasing direct ownership by 94% to 48,569 units (SEC Form 4)
- Director Wolf Dale B bought $244,600 worth of shares (40,000 units at $6.12), increasing direct ownership by 16% to 143,234 units (SEC Form 4)
- AdaptHealth Corp. to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by AdaptHealth Corp.
- AdaptHealth Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- AdaptHealth Corp. Announces Second Quarter 2026 Results
- Cardinal Health expands home care business with two tuck-in acquisitions
- AdaptHealth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health
Latest OPCH
- Option Care Health downgraded by Deutsche Bank with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations